{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Endoscopic+treatment&page=2", "query": { "intervention": "Endoscopic treatment", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Endoscopic+treatment&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-09-28T09:11:44.836Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT07080008", "title": "Evaluation of Lumitrace for Visualizing Ureters During Abdominopelvic Surgeries", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Ureter Injury" ], "interventions": [ { "name": "Lumitrace", "type": "DRUG" }, { "name": "KARL STORZ POWER LED BLUE System", "type": "DEVICE" } ], "intervention_types": [ "DRUG", "DEVICE" ], "sponsor": "MediBeacon", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 10, "start_date": "2026-01-30", "completion_date": "2026-12", "has_results": false, "last_update_posted_date": "2026-08-13", "last_synced_at": "2026-09-28T09:11:44.836Z", "location_count": 1, "location_summary": "Kansas City, Missouri", "locations": [ { "city": "Kansas City", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT07080008" }, { "nct_id": "NCT01525849", "title": "Randomized Evaluation of Maxillary Antrostomy Versus Ostial Dilation Efficacy Through Long-Term Follow-Up", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Chronic Sinusitis" ], "interventions": [ { "name": "Balloon Sinus Dilation", "type": "DEVICE" }, { "name": "Functional Endoscopic Sinus Surgery", "type": "PROCEDURE" } ], "intervention_types": [ "DEVICE", "PROCEDURE" ], "sponsor": "Entellus Medical, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 151, "start_date": "2011-12", "completion_date": "2014-05", "has_results": true, "last_update_posted_date": "2017-02-24", "last_synced_at": "2026-09-28T09:11:44.836Z", "location_count": 1, "location_summary": "Plymouth, Minnesota", "locations": [ { "city": "Plymouth", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT01525849" }, { "nct_id": "NCT04316975", "title": "Utility Of Mutational Load As A Predictor For Endoscopic Treatment Response In Barrett's Esophagus", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Barretts Esophagus With Dysplasia", "Intramucosal Adenocarcinoma" ], "interventions": [ { "name": "Study Driven Procurement of Biopsies", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "University of North Carolina, Chapel Hill", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 75, "start_date": "2020-04-10", "completion_date": "2023-12-20", "has_results": false, "last_update_posted_date": "2024-04-08", "last_synced_at": "2026-09-28T09:11:44.836Z", "location_count": 1, "location_summary": "Chapel Hill, North Carolina", "locations": [ { "city": "Chapel Hill", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT04316975" }, { "nct_id": "NCT02158039", "title": "Endoscopic Ultrasound-guided Ethanol Injection of Pancreatic Cystic Neoplasms", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Neoplasms, Cystic, Mucinous, and Serous" ], "interventions": [ { "name": "Ethanol", "type": "DRUG" }, { "name": "Lidocaine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Mayo Clinic", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 33, "start_date": "2004-06", "completion_date": "2015-09", "has_results": true, "last_update_posted_date": "2018-02-05", "last_synced_at": "2026-09-28T09:11:44.836Z", "location_count": 1, "location_summary": "Rochester, Minnesota", "locations": [ { "city": "Rochester", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT02158039" }, { "nct_id": "NCT03783702", "title": "Pain Control Following Sinus Surgery", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Sinusitis", "Opioid Use", "Opioid Abuse", "Narcotic Use", "Otolaryngologic Disease", "Postoperative Pain", "Pain" ], "interventions": [ { "name": "OxyCODONE 5 Mg (milligram) Oral Tablet", "type": "DRUG" }, { "name": "Ibuprofen 600 Mg (milligram) Oral Tablet", "type": "DRUG" }, { "name": "Acetaminophen 650 MG (milligram) Oral Tablet", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Stanford University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 118, "start_date": "2019-04-04", "completion_date": "2020-12-30", "has_results": true, "last_update_posted_date": "2021-09-01", "last_synced_at": "2026-09-28T09:11:44.836Z", "location_count": 5, "location_summary": "Stanford, California • Evanston, Illinois • Rochester, Minnesota + 2 more", "locations": [ { "city": "Stanford", "state": "California" }, { "city": "Evanston", "state": "Illinois" }, { "city": "Rochester", "state": "Minnesota" }, { "city": "The Bronx", "state": "New York" }, { "city": "Nashville", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT03783702" }, { "nct_id": "NCT04207060", "title": "Trial of Indomethacin in Chronic Pancreatitis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Chronic Pancreatitis" ], "interventions": [ { "name": "Indomethacin", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Endoscopy for Pancreatic Function Testing", "type": "PROCEDURE" } ], "intervention_types": [ "DRUG", "PROCEDURE" ], "sponsor": "Mayo Clinic", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "60 Years", "sex": "ALL", "summary": "18 Years to 60 Years" }, "enrollment_count": 27, "start_date": "2020-07-15", "completion_date": "2023-04-24", "has_results": true, "last_update_posted_date": "2024-09-04", "last_synced_at": "2026-09-28T09:11:44.836Z", "location_count": 2, "location_summary": "Rochester, Minnesota • Columbus, Ohio", "locations": [ { "city": "Rochester", "state": "Minnesota" }, { "city": "Columbus", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT04207060" }, { "nct_id": "NCT06908226", "title": "A Study to Investigate LP352 in Children and Adults With Developmental and Epileptic Encephalopathy (DEE)", "overall_status": "ENROLLING_BY_INVITATION", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Developmental and Epileptic Encephalopathy" ], "interventions": [ { "name": "LP352", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Longboard Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "2 Years", "maximum_age": "66 Years", "sex": "ALL", "summary": "2 Years to 66 Years" }, "enrollment_count": 324, "start_date": "2025-02-12", "completion_date": "2027-12-17", "has_results": false, "last_update_posted_date": "2026-09-15", "last_synced_at": "2026-09-28T09:11:44.836Z", "location_count": 20, "location_summary": "Little Rock, Arkansas • Los Angeles, California • Palo Alto, California + 16 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Los Angeles", "state": "California" }, { "city": "Palo Alto", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Aurora", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT06908226" }, { "nct_id": "NCT03819296", "title": "Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Clinical Stage 0 Cutaneous Melanoma AJCC v8", "Clinical Stage I Cutaneous Melanoma AJCC v8", "Clinical Stage IA Cutaneous Melanoma AJCC v8", "Clinical Stage IB Cutaneous Melanoma AJCC v8", "Clinical Stage II Cutaneous Melanoma AJCC v8", "Clinical Stage IIA Cutaneous Melanoma AJCC v8", "Clinical Stage IIB Cutaneous Melanoma AJCC v8", "Clinical Stage IIC Cutaneous Melanoma AJCC v8", "Clinical Stage III Cutaneous Melanoma AJCC v8", "Clinical Stage IV Cutaneous Melanoma AJCC v8", "Colitis", "Lung Non-Small Cell Carcinoma", "Malignant Genitourinary System Neoplasm", "Malignant Solid Neoplasm", "Pathologic Stage 0 Cutaneous Melanoma AJCC v8", "Pathologic Stage I Cutaneous Melanoma AJCC v8", "Pathologic Stage IA Cutaneous Melanoma AJCC v8", "Pathologic Stage IB Cutaneous Melanoma AJCC v8", "Pathologic Stage II Cutaneous Melanoma AJCC v8", "Pathologic Stage IIA Cutaneous Melanoma AJCC v8", "Pathologic Stage IIB Cutaneous Melanoma AJCC v8", "Pathologic Stage IIC Cutaneous Melanoma AJCC v8", "Pathologic Stage III Cutaneous Melanoma AJCC v8", "Pathologic Stage IIIA Cutaneous Melanoma AJCC v8", "Pathologic Stage IIIB Cutaneous Melanoma AJCC v8", "Pathologic Stage IIIC Cutaneous Melanoma AJCC v8", "Pathologic Stage IIID Cutaneous Melanoma AJCC v8", "Pathologic Stage IV Cutaneous Melanoma AJCC v8", "Stage 0 Lung Cancer AJCC v8", "Stage I Lung Cancer AJCC v8", "Stage IA1 Lung Cancer AJCC v8", "Stage IA2 Lung Cancer AJCC v8", "Stage IA3 Lung Cancer AJCC v8", "Stage IB Lung Cancer AJCC v8", "Stage II Lung Cancer AJCC v8", "Stage IIA Lung Cancer AJCC v8", "Stage IIB Lung Cancer AJCC v8", "Stage III Lung Cancer AJCC v8", "Stage IIIA Lung Cancer AJCC v8", "Stage IIIB Lung Cancer AJCC v8", "Stage IIIC Lung Cancer AJCC v8", "Stage IV Lung Cancer AJCC v8", "Stage IVA Lung Cancer AJCC v8", "Stage IVB Lung Cancer AJCC v8" ], "interventions": [ { "name": "Best Practice", "type": "OTHER" }, { "name": "Biospecimen Collection", "type": "OTHER" }, { "name": "Endoscopic Procedure", "type": "PROCEDURE" }, { "name": "Fecal Microbiota Transplantation", "type": "PROCEDURE" }, { "name": "Infliximab", "type": "BIOLOGICAL" }, { "name": "Laboratory Biomarker Analysis", "type": "OTHER" }, { "name": "Prednisone", "type": "DRUG" }, { "name": "Vedolizumab", "type": "BIOLOGICAL" } ], "intervention_types": [ "OTHER", "PROCEDURE", "BIOLOGICAL", "DRUG" ], "sponsor": "M.D. Anderson Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 800, "start_date": "2021-02-21", "completion_date": "2026-10-31", "has_results": false, "last_update_posted_date": "2026-07-15", "last_synced_at": "2026-09-28T09:11:44.836Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT03819296" }, { "nct_id": "NCT05567003", "title": "Percutaneous Endoluminal Benign Biliary Laser", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Benign Biliary Strictures With Current or Prior Biliary Obstruction" ], "interventions": [ { "name": "Percutaneous transhepatic cholangioscopic (PTCS) laser incision", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE" ], "sponsor": "University of California, Los Angeles", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 5, "start_date": "2022-11-01", "completion_date": "2024-02-05", "has_results": false, "last_update_posted_date": "2025-04-30", "last_synced_at": "2026-09-28T09:11:44.836Z", "location_count": 1, "location_summary": "Los Angeles, California", "locations": [ { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05567003" }, { "nct_id": "NCT00541593", "title": "Natural Orifice Translumenal Endoscopic Surgery (NOTES) Cystgastrostomy for the Treatment of Pancreatic Pseudocysts", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Pancreatic Pseudocyst" ], "interventions": [ { "name": "Pancreatic Pseudocystgastrostomy", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE" ], "sponsor": "Baystate Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "90 Years", "sex": "ALL", "summary": "18 Years to 90 Years" }, "enrollment_count": 5, "start_date": "2007-09", "completion_date": "2011-06", "has_results": true, "last_update_posted_date": "2013-11-07", "last_synced_at": "2026-09-28T09:11:44.836Z", "location_count": 1, "location_summary": "Springfield, Massachusetts", "locations": [ { "city": "Springfield", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT00541593" } ] }